DexCom, Inc. (DXCM) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $87.93 +0.68%
EPS Growth %: +9.8%
Financial Fact:
Operating loss: -18.5M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +9.8%
Financial Fact:
Operating loss: -18.5M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
DexCom, Inc. (NASDAQ: DXCM) reported Q2 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $20.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DexCom (DXCM) PT Raised to $102 at Truist Securities
- Dexcom adds COO role to CFO Jereme Sylvain's duties
- Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss of $0.75/sh
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
